7 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 5 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Drug Therapy, Combination: new trials by email Literature Review of Drug Therapy, Combination trials Research Report on Drug Therapy, Combination
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Drug Combination Therapy - Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Sun Yat-sen University | 30 | 2026-01-01 | 2026-01-21 |
| Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study Blinatumomab - Leukemia, Lymphocytic, Acute, Adult | Not yet recruiting | Shandong University | 36 | 2024-11-01 | 2024-10-18 | |
| Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy Bright White Light Therapy, Combination Drug Therapy, Electronic Health Record Review - Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Recruiting | City of Hope Medical Center | 210 | 2024-07-09 | 2026-10-07 |
| A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia Ribociclib, Combination chemotherapy - HR+HER2- Advanced Breast Cancer | Active not recruiting | Novartis Pharmaceuticals | 376 | 2023-12-28 | 2025-12-05 | |
| Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity Solifenacin with vaginal estrogen cream, Combination pharmacotherapy - Urinary Bladder, Overactive, Effect of Drug | Phase 4 | Recruiting | Mackay Memorial Hospital | 200 | 2022-06-16 | 2025-05-09 |
| Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. combination chemotherapy with Apatinib or Camrelizumab - Advanced Gastric Cancer, Neoadjuvant Therapy | Completed | Fujian Medical University | 234 | 2022-06-01 | 2024-04-19 | |
| Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma Combination Chemotherapy plus Intrathecal Topotecan, Higher Dose Combination Chemotherapy plus Intrathecal Topotecan, Higher Dose Combination Chemotherapy plus Intrathecal Topotecan and Orbital Radiotherapy - Unilateral Retinoblastoma | Phase 3 | Completed | Hospital JP Garrahan | 84 | 2018-01-01 | 2025-04-13 |
| Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer Modified Banxia Xiexin Decoction, combination chemotherapy with Placebo granules - Gastric Cancer (Diagnosis) | Early Phase 1 | Completed | ShuGuang Hospital | 146 | 2017-01-01 | 2023-06-18 |
| Cancer Stem Cell High-Throughput Drug Screening Study Combination Drug Therapy - Glioblastoma Multiforme | Phase 1 | Completed | Swedish Medical Center | 9 | 2015-12-01 | 2024-04-10 |
| A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis Combination Chemotherapy - Germ Cell Tumour | Phase 2 | Completed | Barts & The London NHS Trust | 45 | 2012-05-01 | 2024-06-14 |
| Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC) combination chemotherapy (pemetrexed + cisplatin), thoracic irradiation + pemetrexed - Non-Small Cell Lung Cancer | Phase 2 | Completed | University Hospital, Antwerp | 30 | 2006-02-01 | 2009-04-10 |
| Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) CEP-701, high-dose cytarabine, Mitozantrone, Etoposide, Cytarabine (combination Chemotherapy) - Acute Myeloid Leukemia | Phase 2 | Completed | Cephalon | 224 | 2003-10-01 | 2016-07-21 |
Carcinoma, Non-Small-Cell Lung (1) · Disease (1) · Glioblastoma (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Lung Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Prostatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1) · Urinary Bladder, Overactive (1)
Barts & The London NHS Trust (1) · Cephalon (1) · City of Hope Medical Center (1) · Fujian Medical University (1) · Hospital JP Garrahan (1) · Mackay Memorial Hospital (1) · Novartis Pharmaceuticals (1) · Shandong University (1) · ShuGuang Hospital (1) · Sun Yat-sen University (1) · Swedish Medical Center (1) · University Hospital, Antwerp (1)
United States (3) · China (2) · Russia (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · Germany (1) · Israel (1) · Italy (1) · New Zealand (1) · Poland (1) · Romania (1) · Spain (1) · Sweden (1)
Charles Cobbs, MD (1) · Chunyan Ji, Doctor (1) · Hui-Hsuan Lau, MD (1) · Jonathan Dr Shamash (1) · Mingyu Sun, doctor (1) · Paul R Germonpre, MD PhD (1) · William Dale (1)
P30CA033572 (1)